NCT00095498View on ClinicalTrials.gov

Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL

Enrollment

227

Participants

Timeline

Start Date

August 11, 2004

Primary Completion Date

April 1, 2007

Study Completion Date

April 1, 2007

Conditions

Rheumatoid Arthritis

Interventions

DRUG

placebo

placebo subcutaneous injection

DRUG

denosumab

For subcutaneous injection

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY

NCT00095498 - Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter